Literature DB >> 25110023

Human genetic variation and its effect on miRNA biogenesis, activity and function.

Daniel R Hogg1, Lorna W Harries1.   

Abstract

miRNAs are small non-coding regulators of gene expression that are estimated to regulate over 60% of all human genes. Each miRNA can target multiple mRNA targets and as such, miRNAs are responsible for some of the 'fine tuning' of gene expression and are implicated in regulation of all cellular processes. miRNAs bind to target genes by sequence complementarity, resulting in target degradation or translational blocking and usually a reduction in target gene expression. Like mRNA, miRNAs are transcribed from genomic DNA and are processed in several steps that are heavily reliant on correct secondary and tertiary structure. Secondary structure is determined by RNA sequence, which is in turn determined by the sequence of the genome. The human genome, however, like most eukaryotes is variable. Large numbers of SNPs (single nucleotide polymorphisms), small insertions and deletions (indels) and CNVs (copy number variants) have been described in our genome. Should this genetic variation occur in regions critical for the correct secondary structure or target binding, it may interfere with normal gene regulation and cause disease. In this review, we outline the consequences of genetic variation involving different aspects of miRNA biosynthesis, processing and regulation, with selected examples of incidences when this has potential to affect human disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25110023     DOI: 10.1042/BST20140055

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  15 in total

1.  Association between microRNA polymorphisms and coronary heart disease : A meta-analysis.

Authors:  X Xie; X Shi; X Xun; L Rao
Journal:  Herz       Date:  2016-11-10       Impact factor: 1.443

Review 2.  Diagnostic and therapeutic potential of microRNAs in neuropsychiatric disorders: Past, present, and future.

Authors:  Begum Alural; Sermin Genc; Stephen J Haggarty
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2016-04-09       Impact factor: 5.067

Review 3.  The microRNA feedback regulation of p63 in cancer progression.

Authors:  Changwei Lin; Xiaorong Li; Yi Zhang; Yihang Guo; Jianyu Zhou; Kai Gao; Jing Dai; Gui Hu; Lv Lv; Juan Du; Yi Zhang
Journal:  Oncotarget       Date:  2015-04-20

Review 4.  MicroRNA-Based Therapy in Animal Models of Selected Gastrointestinal Cancers.

Authors:  Jana Merhautova; Regina Demlova; Ondrej Slaby
Journal:  Front Pharmacol       Date:  2016-09-27       Impact factor: 5.810

5.  What is normal? Next generation sequencing-driven analysis of the human circulating miRNAOme.

Authors:  D P Tonge; T W Gant
Journal:  BMC Mol Biol       Date:  2016-02-09       Impact factor: 2.946

6.  Design and implementation of a synthetic pre-miR switch for controlling miRNA biogenesis in mammals.

Authors:  Janina Atanasov; Florian Groher; Julia E Weigand; Beatrix Suess
Journal:  Nucleic Acids Res       Date:  2017-12-15       Impact factor: 16.971

7.  Genetic variation and RNA structure regulate microRNA biogenesis.

Authors:  Noemi Fernandez; Ross A Cordiner; Robert S Young; Nele Hug; Sara Macias; Javier F Cáceres
Journal:  Nat Commun       Date:  2017-05-03       Impact factor: 14.919

Review 8.  Post-transcriptional control of miRNA biogenesis.

Authors:  Gracjan Michlewski; Javier F Cáceres
Journal:  RNA       Date:  2018-10-17       Impact factor: 4.942

9.  Alteration of miRNA Biogenesis Regulating Proteins in the Human Microglial Cell Line HMC-3 After Ischemic Stress.

Authors:  Clara Voelz; Pardes Habib; Stefan Köberlein; Cordian Beyer; Alexander Slowik
Journal:  Mol Neurobiol       Date:  2020-11-19       Impact factor: 5.590

10.  Differential miRNA expression in B cells is associated with inter-individual differences in humoral immune response to measles vaccination.

Authors:  Iana H Haralambieva; Richard B Kennedy; Whitney L Simon; Krista M Goergen; Diane E Grill; Inna G Ovsyannikova; Gregory A Poland
Journal:  PLoS One       Date:  2018-01-30       Impact factor: 3.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.